摘要 |
<p>The present invention relates to a differentiation inducer composition for inducing differentiation of malignant cells, characterized by comprising mono-sodium 5,6-O-benzylidene-L-ascorbate (SBA) as an active ingredient, and a pharmaceutically acceptable carrier; and a use thereof. SBA is useful as a novel differentiation inducing agent showing an excellent differentiation inducing action and having extremely low toxicity.</p> |